Expressing support for the designation of September 2025 as "National Prostate Cancer Awareness Month".
- Bill Number
- H.Res. 675
- Origin Chamber
- House
- Congress
- 119th Congress, Session 1
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2025-09-03: Referred to the House Committee on Energy and Commerce.
- Last Updated
- 2025-12-05T21:31:39Z
AI-Generated Summary
Purpose
This resolution, H. Res. 675, aims to express the House of Representatives' support for designating September 2025 as "National Prostate Cancer Awareness Month." It seeks to highlight the prevalence and risks of prostate cancer, promote early detection and treatment, and encourage public education and research to reduce its impact on men and families.
Key Provisions
The resolution includes factual "Whereas" clauses outlining prostate cancer statistics and needs, followed by a "Resolved" section with three main directives:
- Support for the designation: Affirms backing for "National Prostate Cancer Awareness Month" to focus national attention on the disease.
- Declarations for action:
- Raise awareness about screening methods (like digital rectal exams and prostate-specific antigen blood tests) and treatments.
- Encourage research into better screening, causes, and cures for prostate cancer.
- Promote improvements in access to and quality of health care services for detection and treatment.
- Call to action: Urges the public, interest groups, and affected individuals to:
- Promote awareness of prostate cancer.
- Actively fight its effects on people, families, and the economy.
- Observe the month with ceremonies and activities.
Significant Changes to Existing Law
This is a non-binding resolution, so it introduces no changes to existing laws or statutes. It serves as a symbolic expression of congressional intent rather than enforceable legislation.
Potential Impacts
- On citizens: Increases public awareness of prostate cancer risks, especially for men over 50, African-American men, and those with family history, potentially leading to higher screening rates and earlier detections, which could save lives (e.g., nearly 100% five-year survival with early diagnosis vs. 32% if metastasized).
- On government agencies: Highlights the Department of Veterans Affairs' (VA) role in providing specialized cancer care through 21 Precision Oncology Centers of Excellence, possibly encouraging further federal support for veterans' health programs. No direct funding or mandates are imposed.
- On international relations: No impacts, as the resolution is focused on domestic U.S. health awareness.
- Overall, it fosters a cultural shift toward proactive health education without creating new obligations.
Main Stakeholders Affected
- Men at risk: Particularly the estimated 3.1 million living with prostate cancer diagnoses, 1 in 8 men lifetime risk group, African-American men (higher incidence and mortality), and those with family history.
- Families and communities: Affected by the disease's emotional and economic toll.
- Health care providers and organizations: Groups like the Men's Health Network and American Cancer Society, tasked with promoting screening and education.
- Researchers and veterans: Encourages ongoing research and supports VA services for affected veterans.
- Public and interest groups: Called upon to participate in awareness activities.
Notable Legal, Constitutional, or Political Implications
- Legal: As a simple resolution (H. Res.), it requires only House approval and has no force of law, similar to other awareness designations (e.g., for other cancers or health issues). It does not infringe on constitutional rights.
- Constitutional: Aligns with Congress's broad authority to express policy views under Article I, without executive or judicial involvement.
- Political: Bipartisan sponsorship (e.g., by Reps. Carter, McCormick, Dunn, Lieu, and Menendez) signals unified support for men's health initiatives. It could influence future funding debates for cancer research (e.g., via the National Institutes of Health) or VA programs, but remains symbolic and non-controversial. Referred to the House Committee on Energy and Commerce for consideration.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (6)
Rep. McCormick, Richard [R-GA-7], Rep. Dunn, Neal P. [R-FL-2], Rep. Lieu, Ted [D-CA-36], Rep. Menendez, Robert [D-NJ-8], Rep. Thompson, Mike [D-CA-4], Rep. Miller, Max L. [R-OH-7]
Recent Actions
- 2025-09-03: Referred to the House Committee on Energy and Commerce.
- 2025-09-03: Submitted in House
- 2025-09-03: Submitted in House
Bill Versions
- Expressing support for the designation of September 2025 as "National Prostate Cancer Awareness Month". — issued 2025-09-03 — PDF (4 pages)